Press Releases
Press Releases
| Date | Press Releases | Topic |
|---|---|---|
| Feb 11, 2009 |
Stimulus Debate Highlights Need for Focus on Nanotech Risks The nearly $800 billion stimulus package being debated in Congress contains a number of measures intended to improve information technology, infrastructure and the energy economy in the United States - all areas that will be greatly aided by nanotechnology. However, without an increased focus by the federal government on possible risks posed by engineered nanomaterials, many of the potential societal advancements created by the emerging technology could be compromised. |
Health Topics |
| Apr 29, 2009 |
Statement Urging House to Pass the Credit Cardholders' Bill of Rights "In this economic climate, allowing credit card issuers to continue to engage in unfair and deceptive practices is like letting a car company continue to sell cars we know have faulty brakes. Congress needs to act now to give consumers protection under the law from business practices that the Federal Reserve and our independent research have shown are widespread." |
|
| Sep 2, 2008 |
Statement on Passage of the 'Green Chemistry' Package by the California Legislature Andy Igrejas, manager of The Pew Charitable Trusts' Environmental Health Campaign, today issued the following statement in response to the "Green Chemistry" package passed by the California legislature. |
|
| Mar 10, 2010 |
Statement on Congressional Hearing Regarding FDA Drug Safety Reforms Allan Coukell, director of the Pew Prescription Project, issued the following statement today, commenting on a hearing at the U.S. House Energy and Commerce Subcommittee on Health, where Food and Drug Administration (FDA) Principal Deputy Commissioner Joshua M. Sharfstein is expected to present testimony regarding the agency's ability to protect Americans from unsafe drugs made overseas. |
Drug Manufacturing and Distribution, Drug Safety |
| Oct 5, 2006 |
"The Pew Charitable Trusts extends our warmest congratulations to Craig C. Mello, Ph.D., on his achievement in winning the Nobel Prize in Medicine. Dr. Mello was selected in 1995 as a Pew Scholar in the Biomedical Sciences, receiving support over four years for his research on RNA interference - an investigation that ultimately led to his award-winning discovery..." |
Biomedical Research |
| Sep 26, 2008 |
A GAO report found that the FDA lacks the critical resources necessary for protecting Americans’ health when it comes to food safety. The lack of resources, resulting in too few inspections, too little enforcement and too many gaps in scientific research, is not new and clearly needs to be addressed. |
Food Safety |
| Dec 12, 2008 |
Laura Rogers, project director for the Pew Campaign on Human Health and Industrial Farming, today issued the following statement regarding the U.S. Food and Drug Administration's decision to reverse its plan to ban off-label usage of certain antibiotics in animal agriculture. |
Antibiotics in Food Animal Production |
| Sep 17, 2008 |
Shelley Hearne, managing director, Health & Human Services Policy at The Pew Charitable Trusts, today issued the following statement in response to the decision by South Korea’s Ministry for Food, Agriculture, Forestry and Fisheries to ban the use of seven types of antibiotics in animal feed (the seven antibiotics that South Korea banned from animal feed are: Penicillin, Neomycin, Chlortetracycline, Colistin, Oxytetracycline, Lincomycin, Bacitracin zinc). |
Antibiotics in Food Animal Production |
| Feb 4, 2009 |
"In the midst of an ongoing peanut product recall, the introduction of the Food Safety Modernization Act (FSMA) could not be more timely." |
Food Hazards |
| Jul 16, 2008 |
Statement from Karen Steuer, Pew Environment Group, on Antibiotic Use Reporting Requirements Karen Steuer, director of government operations for the Pew Environment Group, today issued the following statement in response to the House Energy & Commerce Committee mark up of the Animal Drug User Fee Act. |
Antibiotics in Food Animal Production |
